Researchers sought to determine whether elderly, fit patients with AML would respond to therapy with venetoclax plus modified intensive chemotherapy.

Researchers investigated the relationship between the frequency of nurse-led health coaching sessions and clinical outcomes such as health-related quality of life and symptom burden in patients with ...

Changes in law to include screening from age 40 led to increase in screening for Medicaid patients, increased odds of DBT.

Data suggest that “venetoclax usage should be avoided in the general relapsed or refractory multiple myeloma population,” the researchers wrote.